Daniela Hernandez - Concepedia

Author

Daniela Hernandez

Also Known As

Daniela C. Hernandez, Daniela C. Hernández, Daniela Carolina Hernández, Daniela Carolina Hernández-Torres, Daniela Hernandez, Hernandez, D

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center German Rheumatism Research Centre University Medical Center Freiburg University of Freiburg

About

Daniela Hernandez is an author at Johns Hopkins University specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	1.2K
2	Cell Biology	4	4	1.2K
3	Immunology	4	4	1.2K
4	Health Sciences	1	1	965
5	Cellular Therapies	1	1	55

Daniela Hernandez

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition) Andrea Cossarizza, Hyun‐Dong Chang, Andreas Radbruch, European Journal of Immunology Laboratory ImmunologyImmunologyPathologyImmunophenotypingImmune System	2019	965
Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia Richard T. Maziarz, Mark J. Levis, Mrinal M. Patnaik, Bone Marrow Transplantation	2020	144
In Situ Maturation and Tissue Adaptation of Type 2 Innate Lymphoid Cell Progenitors Patrice Zeis, Lian Mi, Xiying Fan, Immunity Tissue AdaptationDevelopmental BiologyLymphocyte DevelopmentImmunologyType 2	2020	135
Role of CYP3A4 in bone marrow microenvironment–mediated protection of FLT3/ITD AML from tyrosine kinase inhibitors Yu-Ting Chang, Daniela Hernandez, Salvador Alonso, Blood Advances	2019	73
An in vitro platform supports generation of human innate lymphoid cells from CD34+ hematopoietic progenitors that recapitulate ex vivo identity Daniela Hernandez, Kerstin Juelke, Nils Müller, Immunity Cell TherapyCd34+ Hematopoietic ProgenitorsLymphocyte DevelopmentVitro PlatformImmunology	2021	55
Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance Salvador Alonso, Daniela Hernandez, Yu‐Ting Chang, Journal of Clinical Investigation	2016	43
Multiplexed histology analyses for the phenotypic and spatial characterization of human innate lymphoid cells Anna Pascual Reguant, Ralf Köhler, Ronja Mothes, Nature Communications	2021	42
Cabozantinib is well tolerated in acute myeloid leukemia and effectively inhibits the resistance‐conferring FLT3/tyrosine kinase domain/F691 mutation Amir T. Fathi, Traci M. Blonquist, Daniela Hernandez, Cancer	2017	30
Regulation of drug metabolizing enzymes in the leukaemic bone marrow microenvironment Meng Su, Yu‐Ting Chang, Daniela Hernandez, Journal of Cellular and Molecular Medicine	2019	20
A novel combination regimen of BET and FLT3 inhibition for FLT3-ITD acute myeloid leukemia Lauren Lee, Yoshiyuki Hizukuri, Paul Severson, Haematologica Hematological MalignancyNovel Combination RegimenMedicineHigh RiskMixed-phenotype Acute Leukemia	2021	15

Page 1